Clinical Trial: Study of Bulevirtide in Participants Who Have Normal or Impaired Liver Function
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Chronic Hepatitis D Infection
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Open-label, Parallel-group, Multiple-dose Study to Evaluate the Pharmacokinetics of Bulevirtide in Participants With Normal and Impaired Hepatic Function
Brief Summary:
The goals of this study are to measure the amount of bulevirtide (BLV) that gets into the blood stream and how long it takes to get rid of it, measure the effect of BLV on bile acids, and evaluate the safety and tolerability of multiple doses of BLV in participants with normal and impaired hepatic (liver) function.
Read more